Detalhe da pesquisa
1.
Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup.
Br J Haematol
; 204(2): 595-605, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37945316
2.
Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3.
Cancer Immunol Immunother
; 73(1): 19, 2024 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240863
3.
Juvenile myelomonocytic leukemia: who's the driver at the wheel?
Blood
; 133(10): 1060-1070, 2019 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30670449
4.
Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
JAMA
; 325(9): 843-854, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33651091
5.
Proteomic Analysis of an Induced Pluripotent Stem Cell Model Reveals Strategies to Treat Juvenile Myelomonocytic Leukemia.
J Proteome Res
; 19(1): 194-203, 2020 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31657576
6.
Lipid Apheresis to Manage Severe Hypertriglyceridemia during Induction Therapy in a Child with Acute Lymphoblastic Leukemia.
Pediatr Hematol Oncol
; 37(6): 530-538, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32374222
7.
DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia.
Semin Cancer Biol
; 51: 68-79, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29129488
8.
LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia.
Blood
; 127(9): 1163-72, 2016 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26712910
9.
First experience of the AML-Berlin-Frankfurt-Münster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acid.
Pediatr Blood Cancer
; 64(8)2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28111878
10.
Priapism from myeloid sarcoma of the sacral canal in a 6-year-old patient.
Pediatr Hematol Oncol
; 39(1): 83-88, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34016030
11.
Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study group.
Br J Haematol
; 172(6): 930-6, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26766110
12.
Tracing the development of acute myeloid leukemia in CBL syndrome.
Blood
; 123(12): 1883-6, 2014 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24493670
13.
Long-term serial xenotransplantation of juvenile myelomonocytic leukemia recapitulates human disease in Rag2-/-γc-/- mice.
Haematologica
; 101(5): 597-606, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26888021
14.
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia.
Haematologica
; 100(1): 17-22, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25552679
15.
Noonan syndrome-associated myeloproliferative disorder with somatically acquired monosomy 7: impact on clinical decision making.
Br J Haematol
; 187(4): E83-E86, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31617209
16.
Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML.
Blood
; 119(11): e96-9, 2012 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22238327
17.
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia.
Leukemia
; 38(1): 136-148, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37945692
18.
Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome.
Blood
; 117(18): 4871-80, 2011 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-21406719
19.
The long non-coding RNA landscape in juvenile myelomonocytic leukemia.
Haematologica
; 103(11): e501-e504, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29858388
20.
Pediatric Acute Lymphoblastic Leukemia: Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia.
Haematologica
; 98(11): 1697-701, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23753025